Category : Seeking Alpha

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

4 hours from now
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

4 hours from now
CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

4 hours from now
OMS Energy 启动 AI+ 机器人研究，进军前景广阔的输油管道检测与维护市场

1 hour from now
OMSエナジー (OMS Energy)、高収益のパイプライン石油検査・保守市場への参入に向けAI+ロボティクスの研究開発を開始

1 hour from now